IM
Immunome, Inc.
IMNM · NASDAQ
$23.93 -0.71% (-$0.17)
1M -21.35%
Market Cap $2.29B
P/E Ratio -
Div. Yield -
ROE 50.56%
Piotroski F-Score Weak
2/9Valuation
46 /100
Fair P/B 4.36x
P/E N/A
P/FFO N/A
Growth
100 /100
Growing Book val. growth 236.47%
EPS growth N/A
FCF growth N/A
Profitability
-
N/A Gross margin N/A
FCF margin N/A
Net margin N/A
Quality
0 /100
Poor ROIC 51.06%
Asset turnover 0.00x
ROE 50.56%
Debt
100 /100
Low Debt/Equity 0.01x
Current ratio 15.08x
Int. coverage N/A
Stability
10 /100
Unstable Beta 2.13x
Profitable years 0
EPS volatility 63.65%
Bulios Scoring opisuje jakość i historię firmy, a nie przyszły zwrot. Wysoki wynik to nie sygnał zakupu. Dowiedz się więcej
Zapytaj StockBota o IMNM
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Clay Siegall
Employees
247
Headquarters
Bothell
Nadchodzące wydarzenia
05 LIS
Earnings
Upcoming earnings report